webinar - surviving sepsis: state of the art

72
SURVIVING SEPSIS: STATE OF THE ART Thursday, May 8 2014 Jeudi 8 mai 2014

Upload: canadian-patient-safety-institute

Post on 22-Nov-2014

251 views

Category:

Health & Medicine


2 download

DESCRIPTION

Intervention: Sepsis Date: Thursday, May 8, 2014 Sponsor: •Canadian Patient Safety Institute •Canadian ICU Collaborative Speakers: •John C. Marshall, MD FACS, St. Michael’s Hospital, University of Toronto Purpose of the Call: Provide update on the Surviving Sepsis Campaign

TRANSCRIPT

Page 1: Webinar - Surviving Sepsis: State of the Art

SURVIVING SEPSIS: STATE OF THE ART

Thursday, May 8 2014 Jeudi 8 mai 2014

Page 2: Webinar - Surviving Sepsis: State of the Art

Your Hosts & Presenters Vos hôtes et présentateurs

Bruce Harries, Moderator

Denny Laporta, MD, FRCPC, CSPQ

Ardis Eliason, Technical Host

John C. Marshall, MD, FRCSC, FACS

2 08/05/2014

Page 3: Webinar - Surviving Sepsis: State of the Art

Interacting in WebEx: Today’s Tools Interagir dans Webex : outils à utiliser

3

Be prepared to use: - Pointer - Raise hand - CHAT - Text Tool “writing on the slide” - Shape Tools

Have you used WebEx before? Avez-vous déjà utilisé WebEx? YES / OUI NO / NON

Soyez prêts à utiliser les outils : - le pointeur - lever la main - clavardage - Outil textuel pour « écrire sur la diapo » - Outils de forme

08/05/2014

Type your message & click ‘send’

Select ‘send to’

Page 4: Webinar - Surviving Sepsis: State of the Art

4

Who’s Online? Qui est en ligne?

POINTER

08/05/2014

Page 5: Webinar - Surviving Sepsis: State of the Art

What professions are represented? Quelles professions sont représentées?

Nurse MD

Educator / Quality Improvement Professional

Infection Control

Administrator / Senior Leader

Other

POINTER

Respiratory Therapist

Nutritionist

5 08/05/2014

Page 6: Webinar - Surviving Sepsis: State of the Art

Dr. John C. Marshall

Surviving Sepsis: State of the Art

Page 7: Webinar - Surviving Sepsis: State of the Art

The Surviving Sepsis Campaign:

State of the Art

St. Michael’s Hospital University of Toronto

John C. Marshall MD FACS

Safer Healthcare Now May 8, 2014

Page 8: Webinar - Surviving Sepsis: State of the Art

Paris, 1997 …

Page 9: Webinar - Surviving Sepsis: State of the Art

• Definitions • Diagnosis of infection • Antibiotics • Hemodynamic support • Source control • ICU care • Adjunctive therapies • Novel therapies

Page 10: Webinar - Surviving Sepsis: State of the Art

Phase 1 Barcelona declaration Phase 2 Evidence-based guidelines Phase 3 Implementation and evaluation

Page 11: Webinar - Surviving Sepsis: State of the Art

A global program to reduce mortality rates in severe sepsis

ESICM, ISF and SCCM

Partially funded by unrestricted educational grants

from Baxter, Edwards, Philips and Lilly

Page 12: Webinar - Surviving Sepsis: State of the Art

Sponsoring Organizations • American Association of Critical Care Nurses • American College of Chest Physicians • American College of Emergency Physicians • American Thoracic Society • Australian and New Zealand Intensive Care Society • European Society of Clinical Microbiology and Infectious

Diseases • European Society of Intensive Care Medicine • European Respiratory Society • International Sepsis Forum • Society of Critical Care Medicine • Surgical Infection Society

Page 13: Webinar - Surviving Sepsis: State of the Art

Guidelines Meeting

London, England

June 2003

Page 14: Webinar - Surviving Sepsis: State of the Art

- Crit Care Med 32:858, 2004

Page 15: Webinar - Surviving Sepsis: State of the Art

The Sepsis Bundles

• Institute for Healthcare Improvement (IHI)

• Measurable activities that indicate compliance with guidelines

Page 16: Webinar - Surviving Sepsis: State of the Art
Page 17: Webinar - Surviving Sepsis: State of the Art

- N Engl J Med 355:1640, 2006

Page 18: Webinar - Surviving Sepsis: State of the Art

San Francisco, January 2006

Page 19: Webinar - Surviving Sepsis: State of the Art

American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians American Thoracic Society Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Society of Critical Care Medicine Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Surgical Infection Society Participation and endorsement by the German Sepsis Society and the Latin American Sepsis Institute.

Sponsors 2006

Page 20: Webinar - Surviving Sepsis: State of the Art

- Crit Care Med 36:296, 2008

Page 21: Webinar - Surviving Sepsis: State of the Art

Miami 2010

Page 22: Webinar - Surviving Sepsis: State of the Art

- Crit Care Med 41:580, 2013

Page 23: Webinar - Surviving Sepsis: State of the Art
Page 24: Webinar - Surviving Sepsis: State of the Art

Grading of Recommendations

Assessment, Development, and Evaluation

• Strength of the Evidence

• Strength of the Recommendation

Page 25: Webinar - Surviving Sepsis: State of the Art
Page 26: Webinar - Surviving Sepsis: State of the Art

Improving Sepsis Care

• Recognition

• Resuscitation

• Diagnosis and treatment of infection

• Physiologic support

Page 27: Webinar - Surviving Sepsis: State of the Art

Improving Sepsis Care

• Recognition

• Resuscitation

• Diagnosis and treatment of infection

• Physiologic support

Page 28: Webinar - Surviving Sepsis: State of the Art

Rates of Sepsis, U.S. 1979 - 2001

- Martin, N Engl J Med 348:1546, 2003

Page 29: Webinar - Surviving Sepsis: State of the Art

Sepsis in the Emergency Department

• Acute change in health status

• Unexplained organ dysfunction

• Febrile illness

• Underlying co-morbidities

Page 30: Webinar - Surviving Sepsis: State of the Art

Sepsis on the

Hospital Ward

• Fever, tachycardia

• Altered mental status

• Fluid retention

• New organ dysfunction

• Often subtle presentation

Page 31: Webinar - Surviving Sepsis: State of the Art

Sepsis

Think of it!

Page 32: Webinar - Surviving Sepsis: State of the Art

Improving Sepsis Care

• Recognition

• Resuscitation

• Diagnosis and treatment of infection

• Physiologic support

Page 33: Webinar - Surviving Sepsis: State of the Art

Optimize Oxygen Delivery to Tissues

• Restore intravascular volume

• Support cardiac function

• Provide oxygen

• Enhance O2 carrying capacity

Page 34: Webinar - Surviving Sepsis: State of the Art

Lactate Metabolism

Anerobic

Aerobic

Page 35: Webinar - Surviving Sepsis: State of the Art

Resuscitation

Page 36: Webinar - Surviving Sepsis: State of the Art

Early Goal-directed Therapy for Septic Shock

Standard Goal-Directed (N=133) (N=130) MVO2 65.3+11.4 70.4+10.7* APACHE II 15.9+6.4 13.0+6.3* Mortality 46.5% 30.5%*

* p<0.02 - Rivers, N Engl J Med 345:1368, 2001

Page 37: Webinar - Surviving Sepsis: State of the Art

CVP

Mean Arterial Pressure > 8

<8 Fluids

ScvO2

> 65 <65

Pressors

Goals achieved > 70 Transfusion,

Inotropes

Page 38: Webinar - Surviving Sepsis: State of the Art

- Angus, N Engl J Med 370:1683, 2014

Page 39: Webinar - Surviving Sepsis: State of the Art

The SAFE Study Investigators, N Engl J Med 2004;350:2247

Saline and Albumin are Equally Efficacious

Page 40: Webinar - Surviving Sepsis: State of the Art

Mortality is Increased with Starches

- Zarychanski, JAMA 309:678, 2013

Page 41: Webinar - Surviving Sepsis: State of the Art

- N Engl J Med 370:1583, 2014

Page 42: Webinar - Surviving Sepsis: State of the Art

- N Engl J Med 370:1583, 2014

Page 43: Webinar - Surviving Sepsis: State of the Art

Improving Sepsis Care

• Recognition

• Resuscitation

• Diagnosis and treatment of infection

• Physiologic support

Page 44: Webinar - Surviving Sepsis: State of the Art

Diagnosis

Antibiotics

Source Control

Page 45: Webinar - Surviving Sepsis: State of the Art

Odd

s R

atio

for D

eath

(9

5% C

I)

1

10

100

Time from Onset of Hypotension (Hours)

-Kumar, Crit Care Med 34:1589, 2006

Impact of Delayed Antibiotic Therapy on Clinical Outcome

Page 46: Webinar - Surviving Sepsis: State of the Art
Page 47: Webinar - Surviving Sepsis: State of the Art

“Early versus late necrosectomy in severe necrotizing pancreatitis”

Number Mortality Early 25 58% Late 11 27%

- Mier et al Am.J.Surg 173:71, 1997

Page 48: Webinar - Surviving Sepsis: State of the Art

Improving Sepsis Care

• Recognition

• Resuscitation

• Diagnosis and treatment of infection

• Physiologic support

Page 49: Webinar - Surviving Sepsis: State of the Art

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury

and the acute respiratory distress syndrome

Mortality (%) Controls 39.8

Volume-limited 31.0*

ARDSNet; NEJM 342:1301, 2000

*P=0.007

Page 50: Webinar - Surviving Sepsis: State of the Art

Impact of Fluid Strategy in ARDS

Conservative Liberal p. (N=503) (N=497) 60 day mortality 25.5% 28.4% 0.30 Ventilator-free days 14.6±0.5 12.1±0.5 <0.001 ICU-free days 13.4±0.4 11.2±0.4 <0.001 CNS failure FD 18.8±0.5 17.2±0.5 0.03

- ARDSNet, N Engl J Med 354:2564, 2006

Page 51: Webinar - Surviving Sepsis: State of the Art
Page 52: Webinar - Surviving Sepsis: State of the Art

Survival in NICE/SUGAR

Page 53: Webinar - Surviving Sepsis: State of the Art

Drotrecogin alfa was ineffective in low risk patients …

Abraham E N Engl J Med 2005;353:1332

Page 54: Webinar - Surviving Sepsis: State of the Art

Time to Shock Reversal

Survival Sprung et al, N Engl J

Med 358:111,2008

CORTICUS

N=499

Page 55: Webinar - Surviving Sepsis: State of the Art

Has It Made a Difference?

Page 56: Webinar - Surviving Sepsis: State of the Art

• Global process change initiative based on “sepsis bundles”

• 15,022 patients enrolled

• 7% absolute, 5.4% relative mortality reduction (p<0.001)

Surviving Sepsis Campaign

Page 57: Webinar - Surviving Sepsis: State of the Art

Unadjusted Risk-adjusted

Bundle target Population N OR p-value

OR 95% CI p-value

Measure Lactate All 15,022 0.86 <0.0001

0.97 [0.90, 1.05] 0.48

Obtain blood cultures before antibiotics All 15,022

0.70 <0.0001 0.76 [0.70, 0.83] <0.0001

Commence broad-spectrum antibiotics All 15,022

0.78 <0.0001 0.86 [0.79, 0.93] <0.0001

Achieve tight glucose control All 15,022 0.65 <0.0001

0.67 [0.62, 0.71] <0.0001

Administer drotrecogin alfa Multi-organ failure 8,733 0.90 0.26

0.84 [0.69, 1.02] 0.07

Administer drotrecogin alfa Shock despite fluids 7,854 0.91 0.30

0.81 [0.68, 0.96] 0.02

Administer low-dose steroids Shock despite fluids 7,854 1.06 0.18

1.06 [0.96, 1.17] 0.24

Demonstrate CVP ≥ 8 mm Hg Shock despite fluids 7,854 1.08 0.10

1.00 [0.89, 1.12] 0.98

Demonstrate ScvO2 ≥ 70% Shock despite fluids 7,854 0.94 0.24

0.98 [0.86, 1.10] 0.69

Achieve low plateau pressure control Mechanical ventilation 7,860 0.67 <0.0001

0.70 [0.62, 0.78] <0.0001

Page 58: Webinar - Surviving Sepsis: State of the Art

- Kaukonen et al JAMA 2014

Survival in Sepsis is Improving

Page 59: Webinar - Surviving Sepsis: State of the Art

Conclusions • The SSC has raised awareness regarding sepsis management and defined optimal approaches to care

• This has been associated with improved survival

• But the elements responsible for that improvement need further study

Page 60: Webinar - Surviving Sepsis: State of the Art

Thank You!!

Page 61: Webinar - Surviving Sepsis: State of the Art

QUESTIONS?

RAISE YOUR HAND / LEVEZ LA MAIN

OR/OU

CHAT TO “ALL PARTICIPANTS”

Page 62: Webinar - Surviving Sepsis: State of the Art

62

a Canadian Critical Care Knowledge Translation Network

“aC3KTion Net”

Page 63: Webinar - Surviving Sepsis: State of the Art

63

aC3KTion Net • Network of ICUs (Networks) from across

Canada • Academic • Community

• Primary activity will be Knowledge Translation and development of Critical Care Knowledge Synthesis products

• Not KT Research

• Measurement of uptake/outcomes

Page 64: Webinar - Surviving Sepsis: State of the Art

64

Network Activities • Measurement of current practice • Knowledge Synthesis: Development of clinical practice guidelines,

evidence syntheses and scoping reviews.

• Testing of Knowledge Products: Reviewed and tested before implementation, to ensure acceptability, ability to achieve intended purpose and ascertain possible barriers

• Knowledge Implementation: Local teams will use strategies/tools tailored to knowledge product. – Education, protocols, checklists, order sets, organizational changes and

reminder systems – PDSA cycles to track implementation activities

Page 65: Webinar - Surviving Sepsis: State of the Art

65

Even when motivated to change our behavior, we cannot manage what we do not measure.

Measurement can identify gaps in best practice.

Measurement can illuminate the results of our efforts at implementing best practice.

Measurement can inform future research direction.

Measurement- Why?

Page 66: Webinar - Surviving Sepsis: State of the Art

Model for Participation • Main benefits of participation

– Access to KT activities/initiatives – Access to KS products – Access to educational events/webinars – Access to a repository of knowledge products, protocols etc. – Opportunity to participate in incubator units – Ability to influence network activities – Benchmarked reports of performance with national peers – A vehicle to drive critical care quality improvement

• ICUs provide periodic data in return

66

Page 67: Webinar - Surviving Sepsis: State of the Art

Current Status

• Baseline Data Collection – Started and ongoing. Site recruitment ongoing.

• Development of barriers/enablers Questionnaires – Completed

• Repository of KT tools/Products – Being populated

• KT activities – Slated for 2014

67

Page 68: Webinar - Surviving Sepsis: State of the Art

68

Questions/Comments?

Page 69: Webinar - Surviving Sepsis: State of the Art

Canadian ICU Collaborative Faculty

Paule Bernier, P.Dt., Msc, Présidente, Ordre professionnel des diététistes du Québec; Sir MB David Jewish General Hospital (McGill University), Montreal

Paul Boiteau MD, Department Head, Critical Care Medicine, Alberta Health Services; Professor of Medicine, University of Calgary Mike Cass, BSc, RN, MScN, Advanced Practice Nurse, Trillium Health Centre Leanne Couves, Improvement Advisor, Improvement Associates Ltd. Maryanne D’Arpino, Patient Safety Improvement Lead, CPSI Bruce Harries, Collaborative Director, Improvement Associates Ltd. Denny Laporta MD, Intensivist, Department of Adult Critical Care, Jewish General Hospital; Faculty of Medicine, McGill University Claudio Martin MD,Intensivist, London Health Sciences Centre, Critical Care Trauma Centre; Professor of Medicine and Physiology,

University of Western Ontario; Chair/Chief of Critical Care Western Cathy Mawdsley, RN, MScN, CNCC; Clinical Nurse Specialist – Critical Care, London Health Sciences Centre; John Muscedere MD, Assistant Professor of Medicine, Queens University; Intensivist, Kingston General Hospital Yoanna Skrobik MD, Intensivist, Hôpital Maisonneuve Rosemont, Montréal; Expert Panel for the new Pain, Sedation and Delirium

Guidelines, Society of Critical Care Medline (SCCM)

69 08/05/2014

Page 70: Webinar - Surviving Sepsis: State of the Art

Reminders Rappels

Call is recorded Slides and links to

recordings will be available on Safer Healthcare Now! Communities of Practice

Additional resources are available on the SHN Website and Communities of Practice

L'appel est enregistré Les diapositives et liens

vers les enregistrements seront disponibles sur Des soins de santé plus sécuritaires maintenant! Communautés de pratique

Des ressources supplémentaires sont disponibles sur le site Web SSPSM et Communautés de Pratique

70 08/05/2014

Page 71: Webinar - Surviving Sepsis: State of the Art

THANK YOU MERCI

Page 72: Webinar - Surviving Sepsis: State of the Art

This National Call is hosted by:

Supported by:

72 08/05/2014